Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion

Tissue Antigens

Volumn 66, Issue 4, 2005, Pages 267-276

  Denis, L ^a   Sivula, J ^b   Gourraud, P A ^c   Kerdudou, N ^a   Chout, R ^d   Ricard, C ^e   Moisan, J P ^f   Gagne, K ^a   Partanen, J ^b   Bignon, Jean Denis ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

^c INSERM   (France)

^d CHR Pointe a Pitre ^*  (Guadeloupe)

^e CHR Saint Denis   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Genetic diversity; KIR genes; NK cells; Populations

Indexed keywords

CELL MARKER; CELL RECEPTOR; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LIGAND; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; DONOR; ETHNOLOGY; FINLAND; FRANCE; GENE; GENETIC CODE; GENETIC DISTANCE; GENETIC INCOMPATIBILITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GUADELOUPE; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; KIR GENE; MAJOR CLINICAL STUDY; MOLECULAR PHYLOGENY; NATURAL KILLER CELL; PATIENT SELECTION; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN FAMILY; REUNION; SENEGAL;

ALLELES; FEMALE; FINLAND; FRANCE; GENE FREQUENCY; GENETICS, POPULATION; GENOTYPE; GUADELOUPE; HLA ANTIGENS; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; REUNION; SENEGAL;

EID: 26044455966     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00473.x     Document Type: Article

References (47)

1. Lanier LL. NK cell receptors. Annu Rev Immunol 1998: 16: 359-93.
2. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002: 20: 217-51.
3. Mingari MC, Schiavetti F, Ponte M et al. Human CD8++ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA 1996: 93: 12433-8.
4. Suto Y, Ishikawa Y, Kasahara M et al. Gene arrangement of the killer cell inhibitory receptor family on human chromosome 19q13.4 detected by fiber-FISH. Immunogenetics 1998: 48: 235-41.
5. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A1,2. J Immunol 1996: 156: 3098-101.
6. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994: 180: 537-43.
7. Pende D, Biassoni R, Cantoni C et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996: 184: 505-18.
8. Moretta A, Sivori S, Vitale M et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995: 182: 875-84.
9. Colonna M, Brooks E, Falco M, Ferrara GB, Strominger JL. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 1993: 260: 1121-4.
10. Campbell KS, Dessing M, Lopez-Botet M, Cella M, Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med 1996: 184: 93-100.
11. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999: 17: 875-904.
12. Moretta A, Bottino C, Vitale M et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001: 19: 197-223.
13. Uhrberg M, Valiante N, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997: 7: 753-63.
14. Wilson MJ, Torkar M, Haude A et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 2000: 25: 4778-83.
15. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002: 54: 221-9.
16. Husain Z, Alper CA, Yunis EJ, Dubey DP. Complex expression of natural killer receptor genes in single natural killer cells. Immunology 2002: 106: 373-80.
17. Valiante NM, Uhrberg M, Shilling HG et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997: 7: 739-51.
18. Crum KA, Logue SE, Curran MD, Middleton D. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 2000: 56: 313-26.
19. Norman PJ, Carrington CV, Byng M et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun 2002: 3: 86-95.
20. Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 1999: 68: 1784-9.
21. Gardiner CM, Guethlein LA, Shilling HG. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 2001: 166: 2992-3001.
22. Rajalingam R, Gardiner CM, Canavez F, Vilches C, Parham P. Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. Tissue Antigens 2001: 57: 22-31.
23. Shilling HG, Lienert-Weindenbach K, Valiante NM, Uhrberg M, Parham P. Evidence for recombination as a mechanism for KIR diversification. Immunogenetics 1998: 48: 413-6.
24. Shilling HG, Young N, Guethlein LA et al. Genetic control of human NK cell repertoire. J Immunol 2002: 169: 239-47.
25. Vely F, Peyrat M, Couedel C et al. Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J Immunol 2001: 166: 2487-94.
26. Denis L, Gagne K, Gueglio B et al. Kinetics of NK-KIR transcripts correlates with acute Graft-versus-Host-Disease occurrence in Allogeneic Bone Marrow Transplantation. Hum Immunol 2005: 66: 447-59.
27. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001: 19: 291-330.
28. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990: 11: 237-44.
29. Parham P. NK cells, MHC class I antigens and missing self. Immunol Rev 1997: 155-221.
30. Rajalingam R, Krausa P, Shilling HG et al. Distinctive KIR and HLA diversity in a panel of North Indian Hindus. Immunogenetics 2002: 53: 1009-19.
31. Yawata M, Yawata N, McQueen KL et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics 2002: 54: 543-50.
32. Cook MA, Moss PA, Briggs DC. The distribution of 13 killer-cell immunoglobulin-like receptor loci in UK blood donors from three ethnic groups. Eur J Immunogenet 2003: 30: 213-21.
33. Niokou D, Spyropoulou-Vlachou M, Darlamitsou A, Stavropoulos-Giokas C. Distribution of killer cell immunoglobulin-like receptors in the Greek population. Hum Immunol 2003: 64: 1167-76.
34. Yin XL, Guo KY, Ma HJ et al. Killer immunoglobulin-like receptor gene distribution in Guangdong Han population. Di Yi Jun Yi Da Xue Xue Bao 2004: 24: 1416-8.
35. Norman PJ, Stephens HA, Verity DH, Chandanayingyong D, Vaughan RW. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 2001: 52: 195-205.
36. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002: 295: 2097-100.
37. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
38. Gagne K, Brizard G, Gueglio B et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002: 63: 271-80.
39. Gomez-Lozano N, Vilches C. Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens 2002: 59: 184-93.
40. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002: 169: 5118-29.
41. Marsh SG, Parham P, Dupont B et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol 2003: 64: 648-54.
42. Reynolds J, Weir BS, Cockerman CC. Estimation for the coancestry coefficient: basis for a short-term genetic distance. Genetics 1983: 105: 767-79.
43. Toneva M, Lepage V, Lafay G et al. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 2001: 57: 358-62.
44. Asai O, Longo DL, Tian ZG et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 1998: 101: 1835-42.
45. Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med 1987: 165: 1212-7.
46. Zeis M, Uharek L, Glass B, Gaska T, Gassmann W, Mueller-Ruchholtz W. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts. Bone Marrow Transplant 1994: 14: 711-5.
47. Giebel S, Locatelli F, Lamparelli T et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003: 102: 814-9.